Concepedia

Koh Furugaki

KF

Statistics

Publications

16

Citations

924

H-Index

14

Active since

2005

Affiliations

Chugai Pharma (United States)(Current)

Kindai University

Kobe University

The University of Tokyo

Kyoto University

Koh Furugaki is an author at Chugai Pharma (United States) specializing in medicine, tumor biology, and oncology.

ORCID

Top concepts

Publications per year

2005–2023

16

Publications

16

Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models

Yoriko Yamashita‐Kashima, Shigeyuki Iijima, Keigo Yorozu et al. · Clinical Cancer Research · 2011 · 176 citations · Full text

Whole genome association study of rheumatoid arthritis using 27 039 microsatellites

Gen Tamiya, Minori Shinya, Tadashi Imanishi et al. · Human Molecular Genetics · 2005 · 136 citations · Full text

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells

Kiyotaka Nakano, Tetsuro Orita, Jun‐ichi Nezu et al. · Biochemical and Biophysical Research Communications · 2008 · 109 citations

, , +7

Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model

Chinami Masuda, Mieko Yanagisawa, Keigo Yorozu et al. · International Journal of Oncology · 2017 · 82 citations · Full text

, , +16

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation

Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki et al. · Nature Communications · 2020 · 80 citations · Full text

1–5 of 16